Public-registry site landscape for NCT02102022, a Advanced Gastrointestinal (GI) Malignancies study sponsored by Polaris Group. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02102022 (registry record) |
| Sponsor | Polaris Group |
| Condition(s) | Advanced Gastrointestinal (GI) Malignancies; Hepatocellular Carcinoma; Gastric Cancer; Colorectal Cancer |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 35 |
| Site countries | United States, China, Italy, South Korea, Taiwan, United Kingdom |
Eichor generates a preliminary site-risk snapshot for NCT02102022 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →